Giant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express08-05

Giant Biogene Holding Co., Ltd announced that its board of directors will convene on 18 August 2026 to consider and approve the Group’s interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration and payment of an interim dividend, if any, and the handling of other routine business matters.

The notice, dated 5 August 2026, confirms that Executive Chairman Yan Jianya will preside over a board composed of five executive directors—Yan Jianya, Ye Juan, Fang Juan, Zhang Huijuan and Yan Yubo—and three independent non-executive directors—Huang Jin, Shan Wenhua and Wong Sze Wing.

The forthcoming meeting will determine the Group’s half-year financial disclosures and any shareholder return via an interim dividend, providing investors with official insight into Giant Biogene’s operating performance for the first half of 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180730358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180730358","market":"us","top_or_hot":-1,"title":"Giant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>Giant Biogene Holding Co., Ltd announced that its board of directors will convene on 18 August 2026 to consider and approve the Group’s interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration and payment of an interim dividend, if any, and the handling of other routine business matters.</p>\n<p>The notice, dated 5 August 2026, confirms that Executive Chairman Yan Jianya will preside over a board composed of five executive directors—Yan Jianya, Ye Juan, Fang Juan, Zhang Huijuan and Yan Yubo—and three independent non-executive directors—Huang Jin, Shan Wenhua and Wong Sze Wing.</p>\n<p>The forthcoming meeting will determine the Group’s half-year financial disclosures and any shareholder return via an interim dividend, providing investors with official insight into Giant Biogene’s operating performance for the first half of 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Giant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGiant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Giant Biogene Holding Co., Ltd announced that its board of directors will convene on 18 August 2026 to consider and approve the Group’s interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration and payment of an interim dividend, if any, and the handling of other routine business matters.</p>\n<p>The notice, dated 5 August 2026, confirms that Executive Chairman Yan Jianya will preside over a board composed of five executive directors—Yan Jianya, Ye Juan, Fang Juan, Zhang Huijuan and Yan Yubo—and three independent non-executive directors—Huang Jin, Shan Wenhua and Wong Sze Wing.</p>\n<p>The forthcoming meeting will determine the Group’s half-year financial disclosures and any shareholder return via an interim dividend, providing investors with official insight into Giant Biogene’s operating performance for the first half of 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02367","symbol_name":"巨子生物","start_time":0,"source_url":"","article_id":"1180730358","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180730358","pubTimestamp":1785919985,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Giant Biogene Holding Co., Ltd announced that its board of directors will convene on 18 August 2026 to consider and approve the Group’s interim results for the six months ended 30 June 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02367":"巨子生物"},"translate_title":"Giant Biogene 定于 2026 年 8 月 18 日召开董事会会议，审查 26 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"Giant Biogene Holding Co., Ltd announced that its board of directors will convene on 18 August 2026 to consider and approve the Group’s interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration and payment of an interim dividend, if any, and the handling of other routine business matters.\nThe notice, dated 5 August 2026, confirms that Executive Chairman Yan Jianya will preside over a board composed of five executive directors—Yan Jianya, Ye Juan, Fang Juan, Zhang Huijuan and Yan Yubo—and three independent non-executive directors—Huang Jin, Shan Wenhua and Wong Sze Wing.\nThe forthcoming meeting will determine the Group’s half-year financial disclosures and any shareholder return via an interim dividend, providing investors with official insight into Giant Biogene’s operating performance for the first half of 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180730358","isCrawlerRequest":true}